Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the joint association of British clinical diabetologists and UK kidney association (ABCD-UKKA) guideline 2024.
Author
Zac-Varghese, SagenMark, Patrick
Bain, Steve
Banerjee, Debasish
Chowdhury, Tahseen A
Dasgupta, Indranil
De, Parijat
Fogarty, Damian
Frankel, Andrew
Goldet, Gabrielle
Karalliedde, Janaka
Mallik, Ritwika
Montero, Rosa
Sharif, Adnan
Wahba, Mona
Dhatariya, Ketan
McCafferty, Kieran
Lioudaki, Eirini
Winocour, Peter
Publication date
2024-07-06
Metadata
Show full item recordAbstract
The contribution of chronic kidney disease (CKD) towards the risk of developing cardiovascular disease (CVD) is magnified with co-existing type 1 or type 2 diabetes. Lipids are a modifiable risk factor and good lipid management offers improved outcomes for people with diabetic kidney disease (DKD).The primary purpose of this guideline, written by the Association of British Clinical Diabetologists (ABCD) and UK Kidney Association (UKKA) working group, is to provide practical recommendations on lipid management for members of the multidisciplinary team involved in the care of adults with DKD.Citation
Zac-Varghese S, Mark P, Bain S, Banerjee D, Chowdhury TA, Dasgupta I, De P, Fogarty D, Frankel A, Goldet G, Karalliedde J, Mallik R, Montero R, Sharif A, Wahba M, Dhatariya K, McCafferty K, Lioudaki E, Winocour P. Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024. BMC Nephrol. 2024 Jul 6;25(1):216. doi: 10.1186/s12882-024-03664-1.Type
ArticleOther
PMID
38971750Journal
BMC NephrologyPublisher
BioMed Centralae974a485f413a2113503eed53cd6c53
10.1186/s12882-024-03664-1